BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1165473)

  • 1. Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.
    Gershon RK; Askenase PW; Gershon MD
    J Exp Med; 1975 Sep; 142(3):732-47. PubMed ID: 1165473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
    Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
    J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    van Loveren H; Meade R; Askenase PW
    J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
    Van Loveren H; Askenase PW
    J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity.
    Schwartz A; Askenase PW; Gershon RK
    J Immunol; 1977 Jan; 118(1):159-65. PubMed ID: 137262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity.
    Askenase PW; Bursztajn S; Gershon MD; Gershon RK
    J Exp Med; 1980 Nov; 152(5):1358-74. PubMed ID: 6968811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
    Van Loveren H; Den Otter W; Meade R; Terheggen PM; Askenase PW
    J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines.
    Askenase PW; Metzler CM; Gershon RK
    Immunology; 1982 Oct; 47(2):239-46. PubMed ID: 6126431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice.
    Galli SJ; Hammel I
    Science; 1984 Nov; 226(4675):710-3. PubMed ID: 6494907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of contact photosensitivity in mice. VII. Diminished elicitation by reserpine and defective expression in mast cell-deficient mice.
    Miyachi Y; Imamura S; Tokura Y; Takigawa M
    J Invest Dermatol; 1986 Jul; 87(1):39-41. PubMed ID: 3722861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses.
    Van Loveren H; Kraeuter-Kops S; Askenase PW
    Eur J Immunol; 1984 Jan; 14(1):40-7. PubMed ID: 6198182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells.
    Mekori YA; Weitzman GL; Galli SJ
    J Exp Med; 1985 Dec; 162(6):1935-53. PubMed ID: 2933482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine.
    Ptak W; Geba GP; Askenase PW
    J Immunol; 1991 Jun; 146(11):3929-36. PubMed ID: 2033262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions.
    Garssen J; Nijkamp FP; Wagenaar SS; Zwart A; Askenase PW; Van Loveren H
    Immunology; 1989 Sep; 68(1):51-8. PubMed ID: 2807371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of experimental allergic neuritis in rats treated with reserpine.
    Brosnan CF; Tansey FA
    J Neuropathol Exp Neurol; 1984 Jan; 43(1):84-93. PubMed ID: 6607325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of either mast cells or macrophages for elicitation of the response.
    Torii I; Morikawa S; Harada T; Kitamura Y
    Immunology; 1993 Mar; 78(3):482-90. PubMed ID: 8478030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of suramin on the immune responses to sheep red blood cells in mice. I. In vivo studies.
    Brandely M; Lagrange P; Hurtrel B; Motta I; Truffa-Bachi P
    Cell Immunol; 1985 Jul; 93(2):280-91. PubMed ID: 3159481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H; Kato K; Meade R; Green DR; Horowitz M; Ptak W; Askenase PW
    J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mast cells in virus-induced inflammation in the murine central nervous system.
    Mokhtarian F; Griffin DE
    Cell Immunol; 1984 Jul; 86(2):491-500. PubMed ID: 6329524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.